Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years

Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance Capital, April was the biggest month for biotech IPO proceeds in more than five years. The post Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years appeared first on MedCity News.